CLABpredicU---基于临床和生化参数的重症监护病房中CLABSI的AI驱动风险预测
Rijhul Lahariya1, Gargee Anand2, Asim Sarfraz2
1All India Institute of Medical Sciences, Patna, Bihar, India.
American journal of infection control
|May 30, 2025
概括
一个人工智能模型使用常规血液检测准确预测中线相关的血液感染 (CLABSI). 这种人工智能工具有助于在重症监护室早期检测和预防CLABSI.
科学领域:
- 医疗信息学 医疗信息学
- 人工智能在医学中的应用
- 传染病流行病学 传染病流行病学
背景情况:
- 中枢线相关的血液感染 (CLABSI) 是重症监护室 (ICU) 患者发病率和死亡率的重要原因.
- 早期发现CLABSI对于及时干预和改善患者结果至关重要.
- 常规的生化参数为预测建模提供了一个潜在的数据源.
研究的目的:
- 为CLABSI.开发和验证人工智能 (AI) 驱动的预测模型.
- 为了能够在中央线插入后两天内早期检测到CLABSI.
- 为了利用常规的生物化学参数来进行CLABSI风险分层.
主要方法:
- 对成年ICU患者有中心线的回顾性分析.
- 收集人口统计和生物化学数据.
- 使用递归特征消除和验证多个机器学习模型 (XGBoost,后勤回归,SVM,随机森林) 的特征选择.
主要成果:
- 支持矢量机 (SVM) 模型实现了最高的预测性能 (AUC = 0.91).
- 确定了七个关键预测因素,包括前列血时间,国际正常化比率,,,中性粒细胞与淋巴细胞的比率以及尿素/肌素的比率.
- 决策曲线分析表明,有效的风险分层在23%的截止点.
结论:
- 人工智能模型展示了使用随时可用的血液参数进行早期CLABSI预测的巨大潜力.
- 这种方法可以增强早期感染预防策略,特别是在资源有限的环境中.
- 建议进行进一步的外部验证和临床实施,以最大限度地提高这种预测工具的影响.
更多相关视频
相关概念视频
01:27Nursing Clinical Information System
756
Nursing Clinical Information System (NCIS)
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
756
01:25Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
3
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
3
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
123
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
123
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
8
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
8
01:30Acute Coronary Syndrome III: Diagnostic studies
3
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
3